These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22505604)

  • 1. GPCR assay automation for leveraging lead optimization.
    Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
    J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Platform to Enable Fully Automated Cross-Titration Experiments.
    Cassaday J; Finley M; Squadroni B; Jezequel-Sur S; Rauch A; Gajera B; Uebele V; Hermes J; Zuck P
    SLAS Technol; 2017 Apr; 22(2):195-205. PubMed ID: 27864339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tango assay for ligand-induced GPCR-β-arrestin2 interaction: Application in drug discovery.
    Dogra S; Sona C; Kumar A; Yadav PN
    Methods Cell Biol; 2016; 132():233-54. PubMed ID: 26928547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
    Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
    J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards the miniaturization of GPCR-based live-cell screening assays.
    Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
    Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
    Peters MF; Knappenberger KS; Wilkins D; Sygowski LA; Lazor LA; Liu J; Scott CW
    J Biomol Screen; 2007 Apr; 12(3):312-9. PubMed ID: 17307886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology.
    Gioiello A; Piccinno A; Lozza AM; Cerra B
    J Med Chem; 2020 Jul; 63(13):6624-6647. PubMed ID: 32049517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testing for inverse agonism with constitutive receptor systems.
    Kenakin T
    Curr Protoc Pharmacol; 2006 Apr; Chapter 9():Unit9.5. PubMed ID: 22294179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miniaturized GPCR signaling studies in 1536-well format.
    Shultz S; Worzella T; Gallagher A; Shieh J; Goueli S; Hsiao K; Vidugiriene J
    J Biomol Tech; 2008 Sep; 19(4):267-74. PubMed ID: 19137117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening.
    Bretschneider T; Ozbal C; Holstein M; Winter M; Buettner FH; Thamm S; Bischoff D; Luippold AH
    SLAS Technol; 2019 Aug; 24(4):386-393. PubMed ID: 30698995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex GPCR assay in reverse transfection cell microarrays.
    Mishina YM; Wilson CJ; Bruett L; Smith JJ; Stoop-Myer C; Jong S; Amaral LP; Pedersen R; Lyman SK; Myer VE; Kreider BL; Thompson CM
    J Biomol Screen; 2004 Apr; 9(3):196-207. PubMed ID: 15140381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of an automated enhanced-throughput platform for functional characterization of positive allosteric modulator-induced leftward shifts in apparent agonist potency in vitro.
    Hendricson A; Matchett M; Ferrante M; Ferrante C; Hunnicutt E; Westphal R; Kostich W; Huang Y; Masias N; Hong D; Bertekap R; Burford N; Watson J; Alt A; Myslik J; Zhang L; Knox R
    J Lab Autom; 2012 Apr; 17(2):104-15. PubMed ID: 22357567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening for Allosteric Modulators of GPCRs.
    Bertekap RL; Burford NT; Li Z; Alt A
    Methods Mol Biol; 2015; 1335():223-40. PubMed ID: 26260604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. cAMP assays in GPCR drug discovery.
    Vasudevan NT
    Methods Cell Biol; 2017; 142():51-57. PubMed ID: 28964339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein coupled receptors virtual screening using genetic algorithm focused chemical space.
    Sage C; Wang R; Jones G
    J Chem Inf Model; 2011 Aug; 51(8):1754-61. PubMed ID: 21761904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update of novel screening methods for GPCR in drug discovery.
    Chen L; Jin L; Zhou N
    Expert Opin Drug Discov; 2012 Sep; 7(9):791-806. PubMed ID: 22716301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miniaturization of whole live cell-based GPCR assays using microdispensing and detection systems.
    Kornienko O; Lacson R; Kunapuli P; Schneeweis J; Hoffman I; Smith T; Alberts M; Inglese J; Strulovici B
    J Biomol Screen; 2004 Apr; 9(3):186-95. PubMed ID: 15140380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers.
    Harvey JH; van Rijn RM; Whistler JL
    Methods Mol Biol; 2013; 995():43-54. PubMed ID: 23494371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.